Загрузка...
Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention
INTRODUCTION: Variability in individual response profiles to antiplatelet therapy, in particular clopidogrel, is a well-established phenomenon. Genetic variations of the cytochrome P450 (CYP) 2C19 enzyme, a key determinant in clopidogrel metabolism, have been associated with clopidogrel response pro...
Сохранить в:
| Опубликовано в: : | Expert Rev Clin Pharmacol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771818/ https://ncbi.nlm.nih.gov/pubmed/28689434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1353909 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|